| Not Yet Recruiting | Wet Heparinized Suction for Abdominal Cancer NCT05041335 | H. Lee Moffitt Cancer Center and Research Institute | N/A |
| Recruiting | Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder NCT07072728 | Psyence Australia Pty Ltd | Phase 2 |
| Active Not Recruiting | LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINT NCT06940778 | Hospital do Coracao | — |
| Not Yet Recruiting | Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Vali NCT06711939 | Mitera Hospital | — |
| Not Yet Recruiting | Omentectomy vs Omental Preservation in Resectable Cancer NCT05747482 | Corporacion Parc Tauli | N/A |
| Recruiting | The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study NCT05804331 | Western Sydney Local Health District | — |
| Terminated | A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HE NCT05311176 | Imugene Limited | Phase 2 |
| Active Not Recruiting | Tempus Priority Study: A Pan-tumor Observational Study NCT05179824 | Tempus AI | — |
| Terminated | Early IntraVenous Administration of Nutritional Support NCT03949907 | Fondazione IRCCS Policlinico San Matteo di Pavia | N/A |
| Unknown | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor NCT03896958 | SpeciCare | — |
| Unknown | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metas NCT03775525 | Genzada Pharmaceuticals USA, Inc. | Phase 1 |
| Completed | Early Support in Primary Care for People Starting Treatment for Cancer NCT03719716 | NHS Lothian | N/A |
| Completed | Nordic Gastric and Esophageal Tumor Study NCT05688761 | Karolinska Institutet | — |
| Unknown | Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastrosco NCT04032353 | Yanqing Li | N/A |
| Completed | Audit of the Spanish EURECCA Esophagogastric Cancer Registry NCT03541629 | Parc de Salut Mar | — |
| Unknown | Investigation of an Abdominal Compression Device NCT04270890 | The Clatterbridge Cancer Centre NHS Foundation Trust | N/A |
| Unknown | Laparoscopic D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers NCT03468712 | West China Hospital | N/A |
| Recruiting | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774 | Massive Bio, Inc. | — |
| Active Not Recruiting | Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer NCT03347162 | Rigshospitalet, Denmark | — |
| Unknown | A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Mi NCT03129139 | Minneamrita Therapeutics LLC | Phase 1 |
| Completed | Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) NCT03133286 | DxTerity Diagnostics | — |
| Completed | Genomic Testing and Resulting Medical Decisions NCT03301493 | Arbeitsgemeinschaft medikamentoese Tumortherapie | — |
| Terminated | Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line Chemotherapy NCT03082833 | Samsung Medical Center | Phase 2 |
| Completed | Real-time Activity Monitoring to Prevent Admissions During RadioTherapy NCT03102229 | Montefiore Medical Center | N/A |
| Completed | Improving Goals of Care Discussion in Advanced Cancer Patients NCT02374255 | Icahn School of Medicine at Mount Sinai | N/A |
| Unknown | Maintenance Treatment With S-1 in Gastric Cancer Patients NCT03701373 | Sun Yat-sen University | Phase 2 |
| Completed | GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric Cancer NCT05088304 | Jinling Hospital, China | — |
| Unknown | NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma NCT02486601 | GERCOR - Multidisciplinary Oncology Cooperative Group | Phase 2 |
| Completed | A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose NCT01614522 | ASLAN Pharmaceuticals | Phase 2 |
| Unknown | Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histol NCT00164892 | Chinese University of Hong Kong | Phase 3 |
| Unknown | Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomac NCT00165048 | Chinese University of Hong Kong | Phase 3 |
| Unknown | Role of Routine Nasogastric Decompression After Subtotal Gastrectomy NCT00164918 | Chinese University of Hong Kong | Phase 3 |
| Terminated | Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophagea NCT00080002 | Enzon Pharmaceuticals, Inc. | Phase 2 |
| Completed | Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer NCT00201747 | Ohio State University Comprehensive Cancer Center | Phase 2 |